About this trial
A prospective randomised multi - center trial on the repair of large hiatal hernias with sutures versus pledgeted sutures versus absorbable mesh
The primary objective of the present trial is to compare the hiatal hernia recurrence rate between three different methods of cruroplasty in large hiatal hernias: hiatal closure with sutures versus pledgeted sutures versus absorbable mesh (Phasix™ST mesh).
The duration of the study is not limited and depends on the number of cases planned. After enrollment in the study, patients will be followed - up with standardized questionnaires and gastroscopy at 6 months, 1 year, 3 years and 5 years after surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with a large hiatal hernia - admitted for surgery (laparoscopic / robot-assisted)
Written informed consent
≥ 18 years of age
> 5cm hiatal hernia
Disqualifiers
Lack of patient consent for study participation
Lack of consent to study due to linguistic or mental incomprehension
Patients in poor general condition (lack of anesthesia ability)
Pregnancy
Trial design
Single group
Treatments tested in this trial
Laparoscopic or robot-assisted hiatal closure (sutures only vs. absorbable mesh vs. pledgeted sutures) and fundoplication according to Toupet
DevicePatients are scheduled to undergo laparoscopic or robot-assisted surgery for a large symptomatic hiatal hernia.The hiatal closure will be done with sutures, pledgeted sutures or absorbable mesh (Phasix™ST mesh). After cruroplasty a fundoplication according to Toupet will be done additionally.
Treatment groups
Trial outcomes
Primary outcomes
Hiatal hernia recurrence rate
Hiatal hernia recurrence rate documented by gastroscopy
Secondary outcomes
Quality of Life evaluated by questionnaire
Quality of Life measured by Gastrointestinal Quality of Life Index (GIQLI)
Symptoms related to Gastroesophageal Reflux Disease (GERD)
Typical and atypical GERD symptoms assessed by the Symptom Check List (SCL) in units of a scale.
Primary extraesophageal GERD symptoms related to Gastroesophageal Reflux Disease (GERD)
Primary atypical GERD symptoms assessed by the Reflux Symptom Index (RSI - Score) in units of a scale
Postoperative complications
Short - term and long - term complications after treatment
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Paracelsus Medical University
Lead sponsor
Medical University Innsbruck
Collaborator
Medical University of Vienna
Collaborator
Krankenhaus Barmherzige Schwestern Linz
Collaborator
Elisabethinen Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options: